Export

ATC codes: L02AE02
Indication
Malignant neoplasms of breast ICD11 code: 2D2Z
INN
Leuprorelin
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > IM: 7.5 mg in prefilled syringe ; 22.5 mg in prefilled syringe
EML status history
First added in 2015 (TRS 994)
Sex
All
Age
Adolescents and adults
Therapeutic equivalence
Medicines within the same pharmacological class can be used
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
Summary of evidence and Expert Committee recommendations
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, leuprorelin (with a square box) was added to the complementary list of the EML for use in treatment protocols for hormone receptor-positive early stage breast cancer. The relevant extract from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for early stage breast cancer is attached.